Study of how common uterine fibroids are in Chinese women and what raises risk
Looks at how common uterine fibroids are and their risk factors in Chinese women.
Key facts
- Who runs it
- Wenwen Wang
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Epidemiology and Risk Factors of Uterine Fibroids in China
- Status
- Recruiting
- People taking part
- 20,000 people, planned
- Started
- 19 Jun 2023
- Expected to end
- 31 Dec 2026
- Type of study
- Observational
- Record updated
- 13 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women in China to answer a survey. It studies how common uterine fibroids are and what raises the chance of getting them.
- Age
- 18 Years and older
- Sex
- Women only
- Disease stage
- Women with or without uterine fibroids can join. Healthy volunteers are accepted.
Main reasons for not taking part
- Living at the current home for less than 6 months
- Serious mental illness or mental abnormality
- Not agreeing to take part or to complete the questionnaire
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Current place of residence≥ 6 months
- No serious mental illness or mental abnormality
- Those who agree to participate in this survey and cooperate in completing the questionnaire
Who cannot take part
- -
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Uterine fibroids are the most common form of benign uterine tumors in the uterine muscle layer, which had a certain rate of malignancy, but it is rare. The prevalence of uterine fibroids estimates range from 4.5% to 68.6% depending on study population and diagnostic methodology. The prevalence of fibroids has been historically underestimated by epidemiologic studies which focused mainly on symptomatic women, leaving behind a large population of asymptomatic women and women who underreport their symptoms. What investigators don't know was which women who have fibroids will develop clinical symptoms and which women who have an operation of myomectomy will relapse. The purpose of this study is to investigate the prevalence, incidence and risk factors for the development of uterine fibroids in Chinese women.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Epidemiology and Risk Factors of Uterine Fibroids in China
- Plain-language title
- Study of how common uterine fibroids are in Chinese women and what raises riskGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Publications
- Record updated
- 13 October 2026